Progeria treatment research. Fluorescent light micrographs showing the blood vessel of an untreated mouse with progeria (left) compared to the blood v


Progeria treatment research. Fluorescent light micrographs showing the blood vessel of an untreated mouse with progeria (left) compared to the blood vessel of a similar mouse treated with the farnsyltransferase inhibitor drug tipifarnib (right). Progeria is a rare genetic disorder that causes a person's body to age at a very early age. Here, tipifarnib has blocked the loss of smooth muscle cells (stained green) in blood vessels, preventing the cardiovascular disease characteristic of progeria.


Size: 4194px × 2085px
Photo credit: © Michelle Olive, NHGRI/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: -, abnormal, animal, biochemical, biochemistry, biological, biology, blood, cardiovascular, circulatory, compared, comparing, comparison, condition, disease, diseased, disorder, drug, farnsyltransferase, fluorescence, fluorescent, genetic, healthy, inhibitor, micrograph, microscope, mouse, normal, pharmaceutic, pharmaceutical, pharmaceutics, pharmacological, pharmacology, photomicrograph, progeria, research, rodent, system, test, testing, treated, treatment, unhealthy, untreated, vascular, vessel, vessels